These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 18243842)
21. 188Re-HDD/lipiodol for treatment of hepatocellular carcinoma: a feasibility study in patients with advanced cirrhosis. Lambert B; Bacher K; De Keukeleire K; Smeets P; Colle I; Jeong JM; Thierens H; Troisi R; De Vos F; Van de Wiele C J Nucl Med; 2005 Aug; 46(8):1326-32. PubMed ID: 16085590 [TBL] [Abstract][Full Text] [Related]
23. Rhenium-188 based radiopharmaceuticals for treatment of liver tumours. Lambert B; Bacher K; Defreyne L Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):305-10. PubMed ID: 19521309 [TBL] [Abstract][Full Text] [Related]
24. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma. Kawaoka T; Aikata H; Takaki S; Katamura Y; Hiramatsu A; Waki K; Takahashi S; Hieda M; Toyota N; Ito K; Chayama K Cardiovasc Intervent Radiol; 2009 Jul; 32(4):687-94. PubMed ID: 19444503 [TBL] [Abstract][Full Text] [Related]
25. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model. Paeng JC; Jeong JM; Yoon CJ; Lee YS; Suh YG; Chung JW; Park JH; Chung JK; Son M; Lee MC J Nucl Med; 2003 Dec; 44(12):2033-8. PubMed ID: 14660730 [TBL] [Abstract][Full Text] [Related]
26. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates. Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301 [TBL] [Abstract][Full Text] [Related]
27. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer. Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599 [TBL] [Abstract][Full Text] [Related]
28. [Radiotherapy with (186)Re-lipiodol II for primary liver cancer patients]. Shi L; Zhang Z; Zhuang D; Cheng H; Gao Y; Wu M Zhonghua Wai Ke Za Zhi; 2002 Nov; 40(11):814-6. PubMed ID: 12487852 [TBL] [Abstract][Full Text] [Related]
29. Combining iodine-131 Lipiodol therapy with low-dose cisplatin as a radiosensitiser: preliminary results in hepatocellular carcinoma. Brans B; Van Laere K; Gemmel F; Defreyne L; Vanlangenhove P; Troisi R; Van Vlierberghe H; Colle I; De Hemptinne B; Dierckx RA Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):928-32. PubMed ID: 12111134 [TBL] [Abstract][Full Text] [Related]
30. Therapy of hepatocellular carcinoma with iodine-131-lipiodol. Results in a large German cohort. Risse JH; Rabe C; Pauleit D; Reichmann K; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H Nuklearmedizin; 2006; 45(4):185-92. PubMed ID: 16964345 [TBL] [Abstract][Full Text] [Related]
31. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383). Rai R; Rai S Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642 [No Abstract] [Full Text] [Related]
32. [131-I-lipiodol in therapy of liver carcinoma--methods and case report]. Stefanović L; Nikolić V; Obradović M; Selir Z; Mihoci Z; Mihailović J; Malesević M Med Pregl; 2001; 54(7-8):387-90. PubMed ID: 11905192 [TBL] [Abstract][Full Text] [Related]
33. Management of multiple intrahepatic recurrences after radiofrequency ablation of hepatocellular carcinoma with rhenium-188-HDD-lipiodol. Kumar A; Bal C; Srivastava DN; Thulkar SP; Sharma S; Acharya SK; Duttagupta S Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):219-23. PubMed ID: 16394805 [TBL] [Abstract][Full Text] [Related]
34. Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary? Bacher K; Brans B; Monsieurs M; De Winter F; Dierckx RA; Thierens H Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1311-6. PubMed ID: 12271412 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and dosimetry of 188 Re-pharmaceuticals. Ferro-Flores G; Arteaga de Murphy C Adv Drug Deliv Rev; 2008 Sep; 60(12):1389-401. PubMed ID: 18547675 [TBL] [Abstract][Full Text] [Related]
36. Treatment of unresectable hepatocellular carcinoma with transarterial radioembolization: iodine-131-lipiodol. Lau WY; Lai EC ANZ J Surg; 2008 May; 78(5):331-2. PubMed ID: 18380721 [No Abstract] [Full Text] [Related]
37. Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma. Huang PW; Tsai SC; Luo TY; Kao CH; Lin WY Ann Nucl Med; 2013 Jul; 27(6):532-7. PubMed ID: 23479326 [TBL] [Abstract][Full Text] [Related]
38. Empirical 188Re-HDD/lipiodol intra-arterial therapy based on tumor volume, in patients with solitary inoperable hepatocellular carcinoma. Shinto AS; Karuppusamy KK; Kurup RER; Pandiyan A; Jayaraj AV Nucl Med Commun; 2021 Jan; 42(1):43-50. PubMed ID: 32956248 [TBL] [Abstract][Full Text] [Related]